Derry Roopenian, Ph.D.
Professor Emeritus
Conducts research to understand why the immune system causes autoimmune diseases and to devise methods to predict and treat them.
The overall goals of our laboratory are to understand why the immune system causes autoimmune diseases and to devise methods to predict and treat them. We develop and use mouse strains that provide models for human diseases such as lupus, rheumatoid arthritis and epidermolysis bullosa. We use a combination of genetics, molecular biological and cellular immunological tools to dissect the molecular and cellular processes that cause these diseases. Finally, we study the mechanisms that affect the persistence of antibodies and antibody-based therapeutics. The information gained from all of these approaches is then used to devise possible therapeutic approaches that can be translated to human treatments.
Education and experience
Education
1972
B.A. Zoology, University of Vermont, Burlington, VT
1984
Ph.D. Pathobiology, University of Minnesota, Minneapolis, MN
Experience
2000-Present
Professor, The Jackson Laboratory, Bar Harbor, ME
2011-Present
Professor, Department of Medicine, Tufts University School of Medicine, Boston, MA
2000-Present
Adjunct Faculty, Department of Biochemistry, Microbiology, and Molecular Biology, University of Maine, Orono, ME
2006-2007
Co-Founder and Chief Scientific Officer, Bar Harbor BioTechnology, Inc., Trenton, ME
1990-1999
Associate Professor, The Jackson Laboratory, Bar Harbor, ME
1985-1990
Assistant Professor, The Jackson Laboratory, Bar Harbor, ME
1985
Research Fellow, Dana-Farber Cancer Institute, Department of Pediatric Oncology, Boston, MA
1984
Research Fellow, Harvard Medical School, Department of Pathology, Boston, MA
1980-1983
Research Assistant, University of Minnesota, Department of Laboratory Medicine and Pathology, Minneapolis, MN
-
Research HighlightOctober 03, 2017Helper cells with heightened self-reactivity identified
The Roopenian lab has identified cell populations that might shed light on origins of autoimmune diseases. -
eNewsDecember 13, 2011
MHC Class 1 Proteins: A Drag on Autoimmune Disease Progression in Mice
Studies in mice reveal that MHC class I proteins act as brakes on autoimmune disease progression in mouse models of lups and B cell lymphoma. -
eNewsFebruary 18, 2010
Engineered antibodies pack greater punch
Two FcRn-“humanized” mouse models developed by JAX Professor Derry Roopenian facilitate the development of preclinical therapeutic antibodies. -
JAX NotesJuly 01, 2009
JAX researcher identifies critical role for IL21 in lupus pathogenesis in mice
A research team lead by JAX Professor Derry Roopenian identified a critical role for interleukin 21 (IL21) in lupus pathogenesis in BXSB/MpJ mice.
-
eNewsApril 01, 2015
Defects in mitochondrial metabolism uncovered in anx/anx mice, a mouse model of anorexia
Anorexia (anx/anx) mutant mice have mitochondrial oxidative phosphorylation (OXPHOS) pathway and complex I assembly defects, suggesting linkage between dysfunctional mitochondrial metabolism and human eating disorders. -
eNewsNovember 29, 2011
FcRn-mediated HIV mucosal vaccine works in mice
A prototype FcRn-mediated HIV-1 vaccine is rapidly transported across mucosal cell barriers, and induces robust, long-term HIV-specific immune responses in mice. -
Search MagazineSeptember 01, 2009A Voice for Lupus
Taylor Hancock is raising awareness about lupus and supporting researchers to find a cure.